RxDoctor Payments Data

Pasquinel Glenn, PA

Physician Assistant · Houston, TXNPI 1912925603

Payments from drug & device makers

$5,095in general payments, 2019–2025

Across 237 payments — averaging $21.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • GSK$1K
  • AstraZeneca$775
  • Mylan Specialty L.p.$656
  • Grifols USA, LLC$476
  • Regeneron Healthcare Solutions, Inc.$409
  • Jazz Pharmaceuticals Inc.$216
  • plus $2K from 23 others

What the payments were for

  • Food & beverage$5,095100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$5,095 in reported general payments places this provider in the 90th percentile of 8,308 physician assistant providers in Texas.

See all physician assistant providers in Texas

Medicare billing

Part B allowed, 2024
$37,825
Medicare patients
222
Services billed
396

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Trelegy ElliptaFluticasone/Umeclidin/Vilanter66$75,132
Breztri AerosphereBudesonide/Glycopyr/Formoterol48$34,674
Breo ElliptaFluticasone/Vilanterol33$19,672
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr24$13,324
SymbicortBudesonide/Formoterol Fumarate29$9,037
Spiriva RespimatTiotropium Bromide11$6,675
Advair HfaFluticasone Propion/Salmeterol15$4,724
Fluticasone-SalmeterolFluticasone Propion/Salmeterol17$2,793
Albuterol Sulfate HfaAlbuterol Sulfate76$2,195
Wixela InhubFluticasone Propion/Salmeterol30$2,124
Ventolin HfaAlbuterol Sulfate31$2,062
Montelukast Sodium50$558
Azithromycin21$125
Pramipexole DihydrochloridePramipexole Di-Hcl17$115
Methylprednisolone11$78

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
GSKTrelegy Ellipta, Breo Ellipta, Anoro Ellipta$1,034$108,128123 claims
AstraZenecaBreztri Aerosphere, Symbicort$775$43,71177 claims
Boehringer IngelheimSpiriva Respimat$162$6,67511 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 8,308 physician assistant providers in Texas.

Other physician assistant in Houston

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →